Data from preclinical studies demonstrates that UNITE, as a nucleic acid platform, elicits potent immune responses in mice June 11, 2020 04:05 PM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, ...
Last year, the National Brain Tumor Society (NBTS) was proud to champion, help introduce and endorse the inaugural Glioblastoma (GBM) Awareness Day. GBM Awareness Day was launched with an official, ...
Date and Time Thu, May 21, 2020: 7:00 PM – 9:00 PM EDT Online Event - Click here “Why does it take so long? Vaccine Development and Clinical Trials” About this ...
Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising projections by over $11M. The Korean investment group HLB Co., LTD led ...
Bill Hearl joins BioTalk host Rich Bendis to discuss their recent successes in funding, research, and their growth in the BioHealth Capital Region Dr. William Hearl is the founder of ...
-ITI Board adds significant oncology drug development and commercialization expertise to the Board- May 05, 2020 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage ...
-Proceeds to support acceleration of Phase II clinical trial for GBM, advancement of pipeline, including development of COVID-19 vaccine candidate and expansion of opportunities for its UNITE nucleic acid platform- ...
GOLDEN, Colo., April 14, 2020 /PRNewswire/ -- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine being ...
ITI Forms Collaboration with EpiVax & PharmaJet to Develop Novel Vaccine Candidate Against COVID-19 Using Its Investigational UNITE Platform
April 09, 2020 04:00 PM Eastern Daylight Time ROCKVILLE, Md. & PROVIDENCE, R.I. & GOLDEN, Colo.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study ...
Accelerate the Discovery, Translation & Clinical Development of Safe, Effective & Deliverable Therapies to Patients in Need Last December, 60+ thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will ...
Society for NeuroOncology Annual Meeting Advancing multi-disciplinary brain tumor research, education, and collaboration to drive discovery and improve patient care https://soc-neuro-onc.org/SNO/News/2020_SNO_Annual_Meeting.aspx
The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on ...